KR20240145458A - 바실러스 메가테리움 균주, 이의 조성물 및 사용 방법 - Google Patents

바실러스 메가테리움 균주, 이의 조성물 및 사용 방법 Download PDF

Info

Publication number
KR20240145458A
KR20240145458A KR1020247022512A KR20247022512A KR20240145458A KR 20240145458 A KR20240145458 A KR 20240145458A KR 1020247022512 A KR1020247022512 A KR 1020247022512A KR 20247022512 A KR20247022512 A KR 20247022512A KR 20240145458 A KR20240145458 A KR 20240145458A
Authority
KR
South Korea
Prior art keywords
renuspore
bacillus
bacillus megaterium
infections
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247022512A
Other languages
English (en)
Korean (ko)
Inventor
존 디튼
Original Assignee
디어랜드 프로바이오틱스 앤드 엔자임스, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 디어랜드 프로바이오틱스 앤드 엔자임스, 인크. filed Critical 디어랜드 프로바이오틱스 앤드 엔자임스, 인크.
Publication of KR20240145458A publication Critical patent/KR20240145458A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/11—Bacillus megaterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
KR1020247022512A 2021-12-08 2022-12-08 바실러스 메가테리움 균주, 이의 조성물 및 사용 방법 Pending KR20240145458A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE20210211 2021-12-08
IE2021/0211 2021-12-08
PCT/US2022/081191 WO2023108077A1 (en) 2021-12-08 2022-12-08 Bacillus megaterium strain, compositions thereof, and methods of use

Publications (1)

Publication Number Publication Date
KR20240145458A true KR20240145458A (ko) 2024-10-07

Family

ID=85158617

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247022512A Pending KR20240145458A (ko) 2021-12-08 2022-12-08 바실러스 메가테리움 균주, 이의 조성물 및 사용 방법

Country Status (10)

Country Link
US (1) US20250170189A1 (https=)
EP (1) EP4444862A1 (https=)
JP (1) JP2024546089A (https=)
KR (1) KR20240145458A (https=)
CN (1) CN119948147A (https=)
AU (1) AU2022408173A1 (https=)
CA (1) CA3239844A1 (https=)
MX (1) MX2024006843A (https=)
WO (1) WO2023108077A1 (https=)
ZA (1) ZA202404360B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118185813A (zh) * 2024-03-15 2024-06-14 宜宾五粮液股份有限公司 普利斯特氏菌及其应用
CN119331870A (zh) * 2024-11-11 2025-01-21 暨南大学 核酸分子、转录元件、表达载体、宿主及其应用
CN119351379B (zh) * 2024-12-11 2025-10-31 昆明理工大学 一种普鲁兰酶PulW310B及其在合成高聚合度麦芽寡糖中的用途
CN119979572A (zh) * 2024-12-31 2025-05-13 湖南农业大学 一种保护农作物免遭精喹禾灵药害的降解基因及其应用
CN121555469A (zh) * 2026-01-23 2026-02-24 江苏海洋大学 一种聚对苯二甲酸乙二醇酯水解酶PmPETase及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020109480A1 (en) * 2018-11-30 2020-06-04 Evonik Operations Gmbh Preparation for use to increase the formation of one or more specialized pro-resolving lipid mediators (spm)
US11160838B2 (en) * 2019-08-09 2021-11-02 Deerland Enzymes, Inc. Antifungal and antimicrobial uses of Bacillus subtilis containing compositions
US12365869B2 (en) * 2023-06-20 2025-07-22 Tenfold Technologies, LLC Systems for production of products to promote nitrogen use efficiency in plants

Also Published As

Publication number Publication date
AU2022408173A1 (en) 2024-06-20
CA3239844A1 (en) 2023-06-15
US20250170189A1 (en) 2025-05-29
ZA202404360B (en) 2025-09-25
MX2024006843A (es) 2024-08-19
JP2024546089A (ja) 2024-12-17
WO2023108077A1 (en) 2023-06-15
EP4444862A1 (en) 2024-10-16
CN119948147A (zh) 2025-05-06

Similar Documents

Publication Publication Date Title
KR20240145458A (ko) 바실러스 메가테리움 균주, 이의 조성물 및 사용 방법
US11752179B2 (en) Medical use of probiotics
JP5693232B2 (ja) グルテン摂取に関連する障害を有する個々の患者の健康向上のための微生物
US8557233B2 (en) Probiotic bifidobacterium strains
KR101840239B1 (ko) 장 염증의 치료에 사용하기 위한 프로바이오틱 조성물
RU2551315C2 (ru) Выделение, идентификация и характеристика штаммов с пробиотической активностью, выделенных из фекалий детей, вскармливаемых исключительно материнским молоком
EP2485743B1 (en) Lactobacillus plantarum strains as hypocholesterolemic agents.
US20220323390A1 (en) Dietary supplement to promote gut health
JP2024539315A (ja) 腸内マイクロバイオーム調節のためのプロバイオティクス組成物
US20250170188A1 (en) Bacillus clausii strain, compositions thereof, and methods of use
US20250161374A1 (en) Bacillus coagulans strain, compositions thereof, and methods of use
US9387229B2 (en) Reuterin-producing Lactobacillus brevis
Arora et al. Therapeutic potential of probiotics: A ray of hope or nightmare?
de Brito Alves et al. Probiotics for humans: Current status and future prospects
Bezirtzoglou Role of Probiotics, Prebiotics, and Synbiotics in the Elderly: Insights Into Their Applications
Alzubaidi Exploration of Beneficial Effects of Urolithins on Obesity Altered Gut Microbiota
HK40104391A (en) Treatment of clostridium difficile infection
Kiruthika et al. PROBIOTICS, PREBIOTICS & SYNBIOTICS–IMPACT ON HEALTH
Unger et al. Probiotics and Health Claims Related to OTC Products and Pharmaceutical Preparations
IE86045B1 (en) Probiotic bifidobacteria strains

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000